It’s
no secret that many pharmaceutical drugs have life-threatening side
effects, but oftentimes they aren’t discussed when the medication is
being prescribed to the patient. It’s important that, when taking any
pharmaceutical drug, you weigh the pros and cons of taking the drug,
because when it comes to pharmaceuticals, the benefits don’t always
outweigh the risks.
Sometimes, the wrong drugs will be
prescribed to patients, but it isn’t very often that Big Pharma
companies get caught literally conspiring to do so. Pharmaceutical
company Insys Therapeutics is currently under investigation for making
it look like patients had cancer (when they did not) so they could sell
their opioid drugs to them.
The Big Pharma corporation used a
variety of tactics to trick both medical staff and patients, including
falsifying medical records, misleading insurance companies, and bribing
doctors, all of which is outlined in a federal indictment on the United States Department of Justice website.
How Insys Faked Cancer Patients to Push Deadly Drugs for Profit
Shortly after Insys was given approval
to sell their opioid drug, they found one very significant problem.
Their drug, a sprayable form of fentanyl called Subsys, was designed to
treat cancer patients with acute pain. However, they soon found that
their market of cancer patients wasn’t quite big enough to match their
profit goals, so they started falsifying information to make it look
like patients had cancer so they could sell more of their drug.
The U.S. Department of Justice document reads:
Several pharmaceutical executives and managers, formerly employed by Insys Therapeutics, Inc., were arrested today on charges that they led a nationwide conspiracy to bribe medical practitioners to unnecessarily prescribe a fentanyl-based pain medication and defraud healthcare insurers.
Whenever
someone needed prior authorization for Subsys, instead of someone from
an actual doctor’s office calling the insurance companies, an Insys
employee would. The insurance companies were tricked into thinking that
they were talking to someone qualified, as Insys employees had a very
strategically worded script to give them that impression and would hide
their caller ID.
The most crucial element of their scheme
surrounded the question of whether the patient had acute pain caused by
cancer, referred to as “breakthrough pain.” Subsys is a drug for cancer
patients, and so insurance companies needed to ensure that the patient
indeed had cancer. Insys would strategically answer this question by
implying that the patient had cancer without specifically saying so.
The authorities have a recording of such
a call, which is frankly astonishing to listen to. It’s easy to see
how the Insys employees got around answering this question but still
made it seem like the patient had “breakthrough pain” from cancer.
You can listen to that recording here,
which involves a conversation between an Insys employee and an
insurance company regarding a New Jersey patient named Sarah Fuller, who
was not diagnosed with cancer but was still prescribed Subsys by her
doctor. Fuller actually passed away of a Subsys overdose, and her
doctor’s license is currently in the process of being suspended.
You can hear the Insys employee stating
that Subsys is “intended for the management of breakthrough cancer
pain” without actually stating that the patient herself has cancer. The
Insys employee also explains that Fuller experiences “breakthrough
pain,” but doesn’t actually say the word “cancer.” It’s tricky wording
like this that leads the insurance representatives to believe that the
patient has cancer, when in reality they don’t.
This fraud and corruption is not going
to be swept under the rug, though. Six former Insys higher-ups and
employees have already been charged, including the former CEO, with
fraud and racketeering crimes in relation to the drug Subsys.
Prosecutors described the
situation as a “nationwide conspiracy to bribe medical practitioners to
unnecessarily prescribe a fentanyl-based pain medication and defraud
health care insurers.”
Special agent Harold Shaw of the FBI explained:
As alleged, top executives of Insys Therapeutics, Inc. paid kickbacks and committed fraud to sell a highly potent and addictive opioid that can lead to abuse and life threatening respiratory depression. In doing so, they contributed to the growing opioid epidemic and placed profit before patient safety. These indictments reflect the steadfast commitment of the FBI and our law enforcement partners to confront the opioid epidemic impacting our communities, while bringing to justice those who seek to profit from fraud or other criminal acts.
Since then, more federal charges have
been announced against those connected to Subsys, and numerous state
attorneys have filed their own lawsuits against other employees
implicated. Though the six executives charged all pled not guilty, other
employees have pled guilty.
Two months ago, former Insys regional
manager Karen Hill pled guilty, giving the court details about how she
trained employees to convince doctors to collude with the company.
“She gave examples that some of her
doctors were motivated by money, chocolate, and spending time with her,”
federal prosecutors stated in a release regarding
her plea. “When the sales representative asked Hill how to identify
doctors who were financially motivated to prescribe Subsys, Hill
explained that she looks for doctors that are ‘money hungry,’ and went
on to describe how to figure out if a doctor has a ‘light in their eyes’
and is willing to ‘play ball.’ “
“Patient safety is paramount and
prescriptions for these highly addictive drugs, especially Fentanyl,
which is among the most potent and addictive opioids, should be
prescribed without the influence of corporate money,” noted United
States Attorney Carmen M. Ortiz.
“I hope that today’s charges send a clear message that we will continue
to attack the opioid epidemic from all angles, whether it is corporate
greed or street level dealing.”
It’s inspiring to see that the justice
system is taking this form of corruption seriously, especially with an
industry as large and powerful as Big Pharma. However, this isn’t the
first time doctors were paid money to push opioids or other
pharmaceutical drugs.
A recently published study in the American Journal of Public Health demonstrated
just how deep this problem of the doctor-opioid relationship
runs, proving that opioids represent a lucrative business for both
physicians and Big Pharma.
The study found that an astonishing 1 in
12 doctors has received money from drug companies marketing opioid
pharmaceuticals. Between August 2013 and December 2015, researchers at
Boston Medical Center found that 68,177 doctors were paid a combined
amount of $46 million from drug companies marketing these drugs. You can
read more about that in our CE article here.
You can even figure out exactly how much
your personal doctor gets paid to sell you drugs, regardless of whether
or not they’re opioids or any other pharmaceutical drug. You can read
more about that in our CE article here and discover how much Big Pharma pays your doctor to prescribe you drugs.
Final Thoughts
Although the U.S. government has been
lenient toward Big Pharma in the past, the situation with Insys clearly
illustrates that they can and will take a stand against Big Pharma.
Let’s hope that this trend continues into the future!
This entire situation also puts the
doctor-patient relationship into question, and makes you wonder why it
is that doctors are compensated when you’re sick rather than when you’re
cured or feeling better. Doctors’ jobs are supposedly to help cure you,
so shouldn’t doctors be paid when they get you off drugs, because that would imply they’ve helped cure you, not to get you on them?
The opioid epidemic is also a huge issue
in and of itself, and I’d encourage you to read the following articles
so you can get a better understanding of how Big Pharma and the U.S.
government played fundamental roles in creating it.
It’s no secret that there’s an opium
epidemic plaguing North America, and it’s been a growing issue for
decades. Many people often picture drug dealers as these scary
individuals selling pills on streets, when in reality, the drug
pushers responsible for the abuse of opioids, opium, and heroin are
largely the U.S. government, pharmaceutical companies, and doctors.
That’s right: The U.S. government and
physicians are deeply connected to the opium trade. You have physicians
as well as Big Pharma heavily pushing and marketing opioids, and then
you have the U.S. government governing the opium trade. It’s very clear
that we need a shift in values in the medical industry, from focusing on
profit to focusing on healing.
No comments:
Post a Comment